{"podcast":{"title":"The Evidence Based Rheumatology Podcast","slug":"the-evidence-based-rheumatology-podcast-1130175","podcast_index_feed_id":1130175,"rss_url":"https://feed.podbean.com/msputman/feed.xml","website_url":"https://msputman.podbean.com","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/2361093/Rheum_Logo-_canvas_size-2.jpg","author":"Michael Putman","episode_count":100,"summary":"A podcast for physicians about evidence based medicine in rheumatology. Each week we'll critique and apply a paper in the medical literature.","last_synced_at":"2026-07-25T20:19:21.829723+00:00","page_url":"https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175"},"episode":{"title":"E137: Obexelimab in IgG4-RD (INDIGO)","slug":"e137-obexelimab-in-igg4-rd-indigo","published_at":"2026-06-29T19:14:56+00:00","page_url":"https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e137-obexelimab-in-igg4-rd-indigo","show_page_url":"https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175","url":"https://msputman.podbean.com/e/e137-obexelimab-in-igg4-rd-indigo/","audio_url":"https://mcdn.podbean.com/mf/web/93p3tikzrv3tcmvs/e137.mp3","summary":"Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a \"maybe less efficacious maybe less toxic\" pathway. I could see folks being excited for this, especially in a disease where non-scary-manifestations are relatively common. Also, check out boardsbank.com! Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2601337","meta_description":"Another day, another B cell drug. This one adds an interesting option for IgG4-RD, offering a \"maybe less efficacious maybe less toxic\" pathway. I could s…","key_points":[],"chapters":[],"topics":[],"duration_seconds":936,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e137-obexelimab-in-igg4-rd-indigo/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e137-obexelimab-in-igg4-rd-indigo.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}